Sarofim Fayez’s GSK GSK Stock Holding History

Sarofim Fayez’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$460K	Buy	+7,330	New	+$472K	﹤0.01%	174

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Sarofim Fayez's GSK Position: Q3 2013 in Review

Sarofim Fayez opened a new position in GSK (GSK) in Q3 2013: 7,330 shares worth $460K. The stake represents ﹤0.01% of the portfolio and ranks #174 among its holdings.

635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

Sarofim Fayez held 7,330 shares of GSK worth $460K as of Q3 2013.
GSK was a new Sarofim Fayez position in Q3 2013.
GSK made up ﹤0.01% of Sarofim Fayez's portfolio in Q3 2013, its #174 holding.
635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Sarofim Fayez's 13F filing for Q3 2013, filed 14 Nov 2013.